Literature DB >> 85686

Distinct functions of monoclonal IgG antibody depend on antigen-site specificities.

W Schalch, J K Wright, L S Rodkey, D G Braun.   

Abstract

Intraveneous hyperimmunization of selectivity bred rabbits with streptococcal group A-variant vaccines elicits antibody responses of restricted heterogeneity at high antibody levels. All antisera contain two functionally distinct antibody populations, which can be isolated in single-band purity upon analytical isoelectric focusing. Typical examples of these two kinds of single-band antibodies were investigated in great detail for several parameters by a variety of methods. 85--99% of the streptococcal group A-variant polysaccharide (Av-CHO)-specific antibody in the antisera does not precipitate the isolated 5,000 daltons poly-L-rhamnose antigen, neither agglutinates nor lyses in the presence of complement Av-CHO-coated sheep erythrocytes (SRBC), binds the radio-labeled Av-CHO with an association constant in the ragne of 10(5)--10(6) M-1, and is of terminal specificity (nonreducing end) for the linear Av-CHO. In contrast, the minor fraction of Av-CHO-specific antibody (1--15%) does precipitate the linear Av-CHO, both agglutinates and lyses Av-CHO-coated SRBC in the presence of complement, has an affinity range of 10(8)--10(9) M-1, and is of internal specificity for the Av-CHO. The antigenic determinants of the Av-CHO for the antibodies are nonoverlapping, only one Fab of the low affinity antibody can be bound whereas four Fab of the high affinity antibody are accommodated. Hence, the determinant specificity explains the functional differences observed, for there is no indication of subclass differences. A mechanistic model of the A-variant carbohydrate presentation on the vaccine appears to account best for the unbalanced levels of low and high affinity antibody.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85686      PMCID: PMC2184852          DOI: 10.1084/jem.149.4.923

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

3.  Immunochemical and chemical studies on streptococcal group-specific carbohydrates.

Authors:  J E Coligan; W C Schnute; T J Kindt
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

4.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

5.  Conversion of incomplete antibodies to direct agglutinins by mild reduction: evidence for segmental flexibility within the Fc fragment of immunoglobulin G.

Authors:  D G Romans; C A Tilley; M C Crookston; R E Falk; K J Dorrington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

6.  High affinity anti-carbohydrate antibodies identified in anti-A-variant streptococcal antisera.

Authors:  J K Wright; W Schalch; L S Rodkey; D G Braun
Journal:  FEBS Lett       Date:  1978-09-15       Impact factor: 4.124

7.  VALENCE AND AFFINITY OF EQUINE NONPRECIPITATING ANTIBODY TO A HAPTENIC GROUP.

Authors:  N R KLIMAN; J H ROCKEY; F KARUSH
Journal:  Science       Date:  1964-10-16       Impact factor: 47.728

8.  Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice.

Authors:  D E Briles; J M Davie
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Studies on the chemical structure of the streptococcal cell wall. II. The composition of group C cell walls and chemical basis for serologic specificity of the carbohydrate moiety.

Authors:  R M KRAUSE; M McCARTY
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line.

Authors:  C H Heusser; C L Anderson; H M Grey
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Autoregulation of immune responses via idiotype network interactions.

Authors:  L S Rodkey
Journal:  Microbiol Rev       Date:  1980-12

2.  Assay dependent specificities of monoclonal antibodies to bacterial antigens.

Authors:  S Ghosh; A M Campbell
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies.

Authors:  D R Bundle; M A Gidney; M B Perry; J R Duncan; J W Cherwonogrodzky
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.

Authors:  S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

Authors:  P Anderson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Affinity-purified interleukin 2 induces proliferation of large but not small B cells.

Authors:  J J Mond; C Thompson; F D Finkelman; J Farrar; M Schaefer; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

7.  Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.

Authors:  M H Nahm; K H Kim; P Anderson; S V Hetherington; M K Park
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Immunochemical specificity of the combining site of murine myeloma protein CAL20 TEPC1035 reactive with dextrans.

Authors:  S Sugii; E A Kabat; M Shapiro; M Potter
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.